Abstracts tagged "Chondrocalcinosis and osteoarthritis"

Abstract Number: 878 • 2019 ACR/ARP Annual Meeting
The Association of Serum Magnesium with Chondrocalcinosis and Osteoarthritis
Devyani Misra¹, Xianbang Sun ², Michael Nevitt ³, Beth Lewis ⁴, James Torner ⁵, Tuhina Neogi ², Alice Lichtenstein ⁶, Nirupa Matthan ⁶ and David Felson ⁷, ¹Beth Israel Deaconess Medical Center, Waban, MA, ²Boston University School of Medicine, Boston, MA, ³University of California at San Francisco, San Francisco, CA, ⁴University of Alabama at Birmingham, Birmingham, AL, ⁵University of Iowa at Iowa City, Iowa City, ⁶Tufts University, Boston, MA, ⁷Boston University School of Medicine, Department of Rheumatology, Boston
Background/Purpose: High serum magnesium (Mg) may have anti-inflammatory effects and prevents the release of extracellular pyrophosphate, inhibiting CPP deposition. Cross-sectional data has linked low serum…
Abstract Number: 1135 • 2017 ACR/ARHP Annual Meeting
the Incidence of Knee Chondrocalcinosis and Its Risk Factors in Community-Based Cohort
Jae-Bum Jun¹, Nam H. Cho², Yoonah Song³, Seunghun Lee⁴ and Yoon-Kyoung Sung¹, ¹Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), ²Department of Preventive Medicine, Ajou University School of Medicine, Suwon, Korea, Republic of (South), ³Department of Radiology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), ⁴Department of Radiology, Hanyang University Hospital, Seoul, Korea, Republic of (South)
Background/Purpose: Chondrocalcinosis (CC) results from deposition of calcium pyrophosphate dihydrate (CPPD) in articular cartilage. It is a relatively common radiographic finding of the joints, especially…
Abstract Number: 2402 • 2015 ACR/ARHP Annual Meeting
Comparison of Synovitis on MRI and Pain in Knee Osteoarthritis Patients with and without Chondrocalcinosis: Data from the Osteoarthritis Initiative (OAI)
Bobby Kwanghoon Han¹, Woojin Kim², Jingbo Niu³, Shristi Basnyat¹, Veniamin Barshay⁴, Charlene Williams⁵, Sharon L. Kolasinski⁶ and David T. Felson³, ¹Division of Rheumatology, Cooper Medical School of Rowan University, Voorhees, NJ, ²Division of Musculoskeletal Radiology, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, ³Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ⁴Department of Radiology, Cooper Medical School of Rowan University, Camden, NJ, ⁵Department of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ, ⁶Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Background/Purpose: CPPD crystals are frequently deposited in the fibrocartilage of the meniscus and detected radiographically as linear calcification, termed chondrocalcinosis (CC). Several studies have found…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].